162 related articles for article (PubMed ID: 25763689)
1. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.
Nittner-Marszalska M; Cichocka-Jarosz E; Sanak M; Wujczyk M; Dor-Wojnarowska A; Lis G; Liebhart J
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):317-25. PubMed ID: 25763689
[TBL] [Abstract][Full Text] [Related]
2. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.
Bochenek G; Nizankowska E; Gielicz A; Swierczyńska M; Szczeklik A
Thorax; 2004 Jun; 59(6):459-64. PubMed ID: 15170023
[TBL] [Abstract][Full Text] [Related]
3. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children.
Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Gielicz A; Pietrzyk JJ
J Investig Allergol Clin Immunol; 2011; 21(4):260-9. PubMed ID: 21721371
[TBL] [Abstract][Full Text] [Related]
4. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
Misso NL; Aggarwal S; Thompson PJ; Vally H
Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
[TBL] [Abstract][Full Text] [Related]
5. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
[TBL] [Abstract][Full Text] [Related]
6. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children.
Cichocka-Jarosz E; Dorynska A; Pietrzyk JJ; Spiewak R
Immunotherapy; 2011 Aug; 3(8):1013-7. PubMed ID: 21843104
[TBL] [Abstract][Full Text] [Related]
7. GC/MS analysis of urinary excretion of 9alpha,11beta-PGF2 in acute and exercise-induced asthma in children.
Nagakura T; Obata T; Shichijo K; Matsuda S; Sigimoto H; Yamashita K; Masaki T; Maekawa K
Clin Exp Allergy; 1998 Feb; 28(2):181-6. PubMed ID: 9515591
[TBL] [Abstract][Full Text] [Related]
8. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
O'Sullivan S
Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children.
Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Pietrzyk JJ
Ann Agric Environ Med; 2014; 21(2):294-301. PubMed ID: 24959779
[TBL] [Abstract][Full Text] [Related]
10. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.
Shin TR; Kim JH; Kim CH; Hyun IG; Choi JH
J Thorac Dis; 2015 Jul; 7(7):1198-204. PubMed ID: 26380736
[TBL] [Abstract][Full Text] [Related]
12. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge.
Bochenek G; Nagraba K; Nizankowska E; Szczeklik A
J Allergy Clin Immunol; 2003 Apr; 111(4):743-9. PubMed ID: 12704352
[TBL] [Abstract][Full Text] [Related]
13. Evidence of mast cell activation and leukotriene release after mannitol inhalation.
Brannan JD; Gulliksson M; Anderson SD; Chew N; Kumlin M
Eur Respir J; 2003 Sep; 22(3):491-6. PubMed ID: 14516140
[TBL] [Abstract][Full Text] [Related]
14. Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction.
Parsons WG; Roberts LJ
J Immunol; 1988 Oct; 141(7):2413-9. PubMed ID: 3139758
[TBL] [Abstract][Full Text] [Related]
15. Determination of 9alpha, 11beta prostaglandin F2 in human urine. combination of solid-phase extraction and radioimmunoassay.
Mucha ; Riutta A
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):271-80. PubMed ID: 11993720
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
O'Sullivan S; Roquet A; Dahlén B; Dahlén S; Kumlin M
Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of 9α,11β-PGF
Wittenberg M; Nassiri M; Francuzik W; Lehmann K; Babina M; Worm M
Allergy; 2017 Nov; 72(11):1801-1805. PubMed ID: 28378321
[TBL] [Abstract][Full Text] [Related]
18. Human liver dihydrodiol dehydrogenase 1-catalyzed reaction generating 9alpha,11beta-prostaglandin F2 from prostaglandin D2 followed by micellar electrokinetic chromatography.
Inagaki S; Esaka Y; Deyashiki Y; Uno B; Hara A; Toyo'oka T
J Sep Sci; 2008 Mar; 31(4):735-40. PubMed ID: 18307166
[TBL] [Abstract][Full Text] [Related]
19. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
20. Urinary 9alpha,11beta-prostaglandin F(2) in children with atopic eczema/dermatitis syndrome: an indicator of mast cell activation?
Øymar K; Aksnes L
Acta Derm Venereol; 2004; 84(5):359-62. PubMed ID: 15370701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
